MedTrace Logo

Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

NCT06487143 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2024-07-05

No results posted yet for this study

Summary

The primary objective of this study is to compare the efficacy of the 3-month formulation and 1-month formulation of triptorelin and to assess the short-term effects of the 3-month formulation of triptorelin on glucose and lipid metabolism, body composition, and bone density in Chinese ICPP patients.

Conditions

  • Central Precocious Puberty

Interventions

DRUG

Triptorelin pamoate（15mg）

Triptorelin pamoate 15mg is administered via intramuscular injection once every three months.

DRUG

Triptorelin acetate （3.75mg）

Triptorelin acetate 3.75mg is administered via intramuscular injection once every four weeks.

Sponsors & Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Zhe Meng, master · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  • Liyang Liang, PhD · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06487143 on ClinicalTrials.gov